thiotepa has been researched along with Opportunistic Infections in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to evaluate the safety and efficacy of oral fluconazole for empirical antifungal therapy in neutropenic patients with persistent fever." | 9.11 | Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation. ( Hardan, I; Maor, Y; Stemmer, SM, 2004) |
| " The aim of the present study was to evaluate the safety and efficacy of oral fluconazole for empirical antifungal therapy in neutropenic patients with persistent fever." | 5.11 | Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation. ( Hardan, I; Maor, Y; Stemmer, SM, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stemmer, SM | 1 |
| Maor, Y | 1 |
| Hardan, I | 1 |
| Williams, SF | 1 |
| Bitran, JD | 1 |
| Kaminer, L | 1 |
| Westbrook, C | 1 |
| Jacobs, R | 1 |
| Ashenhurst, J | 1 |
| Robin, E | 1 |
| Purl, S | 1 |
| Beschorner, J | 1 |
| Schroeder, C | 1 |
1 trial available for thiotepa and Opportunistic Infections
| Article | Year |
|---|---|
Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemo | 2004 |
1 other study available for thiotepa and Opportunistic Infections
| Article | Year |
|---|---|
A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer.
Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantatio | 1987 |